THE U.S. REMOTE PATIENT MONITORING MARKET SIZE WAS VALUED AT USD 11.31 BILLION IN 2021 AND IS EXPECTED TO REACH USD 23 BILLION BY 2027, GROWING AT A CAGR OF 12.6%.

The U.S. Remote Patient Monitoring Market Size, Growth, Share, Trends Analysis Report by:

  • Component
    • Devices & Softwares
      • Cardiac Monitoring Devices, Respiratory Monitoring Devices, Blood Glucose Monitors (Includes Cgm), Fetal & Neonatal Monitoring Devices, Other Rpm Devices
    • Services
  • Application
    • Cardiology Remote Patient Monitoring, Pulmonology Remote Patient Monitoring, Endocrinology Remote Patient Monitoring, And Others
  • Application
    • Hospitals & Specialty Clinics, Homecare Settings, Ambulatory Surgical Centers, Long Term & Acute Care Centers, And Other End Users

Licence Types What are these?
GET ACTIONABLE INSIGHTS ON HOW COVID-19 IS IMPACTING YOUR BUSINESS
Enquire Now Download Free Sample

Most Exhaustive Report

icon-pages

194 Pages

icon-table

60 Tables

icon-chart

81 Charts

icon-region

1 Regions

icon-country

1 Countries

icon-company

44 Companies

icon-market

5 Market Segment

U.S. REMOTE PATIENT MONITORING MARKET REPORT SCOPE

Report Attribute Details
MARKET SIZE (2027) USD 23 Billion
CAGR (2022-2027) 12.6%
BASE YEAR 2021
FORECAST YEAR 2022-2027
MARKET SEGMENTS Component, Applications, and End-Users
GEOGRAPHIC ANALYSIS United States

MARKET OVERVIEW

The U.S. remote patient monitoring market size was valued at USD 11.31 billion in 2021 and is expected to reach USD 23.07 billion by 2027, growing at a CAGR of 12.63 % during the forecast period.

Rising adoption of Telemedicine, increasing prevalence of chronic diseases, and a paradigm shift toward home healthcare to drive the U.S. remote patient monitoring market growth.

 

US Remote Patient Monitoring Market Overview

ANALYST'S VIEWPOINT

According to Arizton market research report, the U.S. remote patient monitoring market is expected to grow between 2021 and 2027, due to the increased demand for remote patient monitoring systems and devices due to the COVID-19 pandemic. The growth of the market can be ascribed to several factors, including technological improvements, a greater focus on public health, more consumer awareness of the benefits of remote patient monitoring devices, and lower prices. The telemedicine approach incorporating remote patient monitoring is growing exponentially. The manufacturers are in the process of making the solutions that are less invasive and more minor and planning to collaborate and partner with new players to expand their market share. Moreover, several traditional medical device manufacturers are gradually expanding their product portfolios and focusing on launching remote patient monitoring devices integrated with advanced technologies, such as the Internet of Things.

The presence of substantial competitors and their growth strategies are the main factors driving the U.S. remote patient monitoring market growth. The market in the US is being driven by rising healthcare spending and increased awareness about the benefits of sickness prevention. Growing recognition of RPM as a tool to proactively monitor and improve patient engagement is expected to boost the market in the United States. The government's involvement in introducing telehealth to rural areas and the existence of significant corporations in the United States contribute to the market growth.

 

Remote Patient Monitoring Systems Working Structure

US RPM Market

Remote patient monitoring is achieved by using digital technologies to monitor and capture medical health-related data from patients and electronically transmit the information to healthcare providers for assessment, and, when necessary, recommendations and instructions to the patients are provided. Remote patient monitoring reduces the number of readmissions in the medical requirement, hospitalizations, and lengths of stay in the hospital, which lead to improved quality of life and contain costs.

Partnership and Product Launches to Increase U.S. Remote Patient Monitoring Market Share

  • In December 2021, Smart Meter, the leader in cellular-enabled remote patient monitoring (RPM) data and devices, announced a partnership with A&D Medical, to develop and deliver top-quality RPM devices that use advanced cellular-enabled technology best to connect patients, caregivers, and healthcare providers.
  • In July 2020, Philips integrated the BioIntelliSense FDA-cleared BioSticker sensor as part of its remote patient monitoring solutions for patients outside the hospital. Multi-parameter sensors aid monitoring across multiple chronic conditions with medical-grade vital signs for physicians to remotely track core symptoms, including COVID-19.

KEY DRIVERS:

Remote Patient Monitoring Market drivers

Increasing Number Of Technology Innovation In Wearable Medical Devices

The wearable health devices are increasingly assisting people in better monitoring their health condition, both on a personal level for self-health tracking and a medical level, by sending more data to professionals, potentially allowing for earlier diagnosis and treatment assistance. The shrinking of electronic devices enables the development of more dependable and flexible wearables, contributing to the health monitoring method. Wearables, like implanted devices, have the advantage of being able to be designed as smart gadgets that can offer digital health data and assist telemedicine. Thanks to technological capabilities in wearables, patients and clinicians can more readily monitor vital signs physiological and biochemical indicators, such as glucose levels and physical activity. Wearable drug delivery systems also provide a dependable method of pharmacological therapy without the need for trained persons to administer it. These capabilities improve the accuracy of patient tests and treatments, resulting in a better patient experience while also lowering healthcare expenditures. These considerations contribute to the growing popularity of remote patient monitoring systems.

The Increased Use Of Mobile Technologies And Smart Devices For Remote Patient Monitoring

Remote monitoring has emerged as a novel and significant telemedicine paradigm over the last decade. COVID-19 necessitates scalable, near-real-time interactions with populations. Remote monitoring, particularly asynchronous communication, has specific operating and design qualities that are ideally suited for COVID-19. Monitoring can collect epidemic data and acquire real-time clinical input in particular. Remote monitoring is becoming a crucial tool for payers, clinicians, and public health officials as telemedicine grow and evolves. COVID-19 is bringing telemedicine to the forefront of national attention, which has been long needed, but it comes at a difficult time. The need for population-level screening has arisen due to COVID-19, and telemedicine is well-positioned to facilitate this. Telemedicine is a key component in the ever-changing environment of a growing epidemic, providing care beyond the traditional face-to-face format. These factors have aided the market expansion of the remote patient monitoring industry.

SEGMENTATION ANALYSIS

The US remote patient monitoring market is bifurcated by component, application, end-user, and region. Based on components, the market is again divided into devices and software, and services. The Devices and Software segment accounts for the largest share than that of the Services segment in the U.S. remote patient monitoring market. The increasing adoption of wearable medical devices, technological advancements in IoT, the rise in the adoption of home healthcare systems are expected to boost the adoption of device & software segment in the remote patient monitoring market.

Ways Healthcare IoT & Remote Patient Monitoring Are Transforming Care Delivery

US Remote Patient Monitoring Market

The cardiology remote patient monitoring systems accounted for the maximum share in the U.S. remote patient monitoring market. According to CDC, 659,000 people in the US die from heart disorders every year which is 1 in every 4 deaths is due to heart diseases. Statistics from the Centers for Disease Control and Prevention (CDC) demonstrate RPM is becoming more popular in cardiology. Nearly one out of every two persons in the US has hypertension, and the majority of these adults do not have their hypertension under control. According to estimates, 6.1 million people in the US have atrial fibrillation (AF), a number that is expected to climb as the population ages. Finally, according to CDC estimates, more than 42% of the American population were obese in 2017–2018, compared to around 31% in 1999–2000. Thus the high incidence of heart diseases in the country is expected to drive the cardiology segment during the forecast period.

The hospitals and specialty clinics accounted for the largest share in the U.S. remote patient monitoring market and the Homecare setting is anticipated to be the fastest-growing end-user. With the increased demand for hospital beds and the challenge of delivering care with staff shortages, some health care centers prefer remote patient monitoring solutions. Moreover, technological advancements have made it viable to monitor patients remotely while at home or in skilled nursing facilities. Wireless monitors, cloud-based platforms, and telemedicine have allowed health systems to seamlessly use at-home continuous pulse oximeters to monitor patients and help avoid hospitalizations all these factors are expected significantly boost the market growth for the Homecare setting segment.

COMPETITIVE LANDSCAPE

With many top companies in the US market and several small players in regional markets, the US remote patient monitoring market is somewhat fragmented. Leading companies dominate the global RPM market. The major competitors in the industry are focusing their efforts on reducing the size of remote patient monitoring devices. These companies are also attempting to increase their market share by launching new goods and forming collaborations with other industry participants. As a result, these factors are expected to increase the remote patient monitoring market size.

Medtronic, Philips Healthcare, and ResMed are among the leading companies in the U.S. remote patient monitoring market for Devices and Software. Withings, MedM, iHealthUnifiedcare, and Qardio are among the top companies in the U.S. remote patient monitoring market services.

100Plus, A&D Medical, Abbott, Altumview Systems, Biotronik, Boston Scientific, Bardy Diagnostics, Cardiomo, Cardiologs, Dragerwerk AG, F. Hoffmann-La Roche Ltd, Fluxion Biosciences, GE Healthcare, GrandCare Systems, Masimo Corporation, Nihon Kohden, Omron Healthcare, OSPLabs, Qualcomm Technologies, Senseonics, VitalConnect, and others are among the leading players in the U.S. remote patient monitoring market.

Frequently Asked Questions

WHAT WILL BE THE SIZE OF THE US REMOTE PATIENT MONITORING MARKET BY 2027?

The US Remote Patient Monitoring Market is expected to reach USD 23 billion by 2027.

WHAT ARE THE FACTORS CONTRIBUTING TO THE U.S. REMOTE PATIENT MONITORING MARKET GROWTH?

An increasing number of technology innovations in wearable medical devices, the increased use of mobile technologies, and smart devices for remote patient monitoring are some of the factors contributing to the market growth.

WHO ARE THE KEY PLAYERS IN THE MARKET?

Medtronic, Philips Healthcare, and ResMed are some of the key players in the market.

WHICH APPLICATION HOLDS THE HIGHEST SHARE IN THE U.S. REMOTE PATIENT MONITORING MARKET?

The cardiology remote patient monitoring segment accounted for the highest share.

WHAT ARE THE LATEST TRENDS IN THE REMOTE PATIENT MONITORING MARKET IN THE US?

Telemedicine, the Increasing role of the Internet of Things (IoT) are some of the latest trends in the market.

Download Free Sample

The US remote patient monitoring market size was valued at USD 11.31 billion in 2021 and is expected to reach USD 23.07 billion by 2027, growing at a CAGR of 12.63%.

The following factors are likely to contribute to the U.S. remote patient monitoring market growth during the forecast period:

  • An increase in the number of technology innovations in wearable medical devices.
  • The increased use of mobile technologies and smart devices for remote patient monitoring.
  • An aging population is vulnerable to chronic disease.
  • Growing recognition of RPM as a tool to proactively monitor and improve patient engagement.

The report considers the present scenario of the U.S. remote patient monitoring market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several other prominent companies operating in the market. 

Base Year: 2021

Forecast Year: 2022-2027

Key Vendors

  • Medtronic
    • Business Overview
    • Product Offerings
  • Philips Healthcare
  • ResMed

Other Prominent Vendors

  • 100-Plus
    • Business Overview
    • Product Offerings
  • A&D Company
  • Abbott
  • AltumView Syste
  • BIOTRONIK
  • Boston Scientific
  • Bardy Diagnostics
  • Cardiomo Care
  • Cardiologs
  • Dragerwerk
  • Hoffmann-La Roche
  • GE Healthcare
  • GrandCare Systems
  • Honeywell International
  • iHealthUnifiedcare
  • Qardio
  • MedM
  • Masimo Corporation
  • Medopad
  • Nihon Kohden
  • Omron Healthcare
  • OSPLabs
  • Resideo Technologies
  • Smiths Medical
  • Spacelabs Healthcare
  • Senseonics
  • TeleMedCare
  • VitalConnect
  • Vitls
  • Modivcare
  • Hill-Rom
  • Vivify Health
  • ACL Digital
  • Dexcom
  • iRhythm Technologies
  • Vivalink
  • Biobeat
  • CareValidate
  • Biofourmis
  • CAREMINDr
  • Datos Health

Segmentation by Component

  • Devices & Software
  • Services

Segmentation by Devices

  • Cardiac Monitoring Devices
  • Respiratory Monitoring Devices
  • Blood Glucose Monitors (Includes CGM)
  • Fetal & Neonatal Monitoring Devices
  • Other Rpm Devices

Segmentation by Application

  • Cardiology Remote Patient Monitoring
  • Pulmonology Remote Patient Monitoring
  • Endocrinology Remote Patient Monitoring 
  • Others

Segmentation by End-User

  • Hospitals & Specialty Clinics
  • Homecare Settings
  • Ambulatory Surgical Centers
  • Long Term & Acute Care Centers
  • Other End Users

1 RESEARCH METHODOLOGY

2 RESEARCH OBJECTIVES

3 RESEARCH PROCESS

4 SCOPE & COVERAGE

4.1 MARKET DEFINITION

4.1.1 INCLUSIONS

4.1.2 EXCLUSIONS

4.1.3 MARKET ESTIMATION CAVEATS

4.2 BASE YEAR

4.3 SCOPE OF THE STUDY

4.3.1 MARKET SEGMENTATION BY COMPONENT

4.3.2 MARKET SEGMENTATION BY APPLICATION

4.3.3 MARKET SEGMENTATION BY END-USER

4.3.4 MARKET SEGMENTATION BY GEOGRAPHY

5 REPORT ASSUMPTIONS & CAVEATS

5.1 KEY CAVEATS

5.2 CURRENCY CONVERSION

5.3 MARKET DERIVATION

6 MARKET AT A GLANCE

7 INTRODUCTION

7.1 OVERVIEW

8 MARKET OPPORTUNITIES & TRENDS

8.1 TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY, & REMOTE MONITORING

8.2 TELEMEDICINE USHERING NEW OPPORTUNITIES FOR REMOTE MONITORING

8.3 INCREASING ROLE OF INTERNET OF THINGS (IOT) IN REMOTE MONITORING & HEALTHCARE

9 MARKET GROWTH ENABLERS

9.1 INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES

9.2 GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING

9.3 AGING POPULATION VULNERABLE TO CHRONIC DISEASES

9.4 GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

10 MARKET GROWTH RESTRAINTS

10.1 REGULATORY VARIATIONS ACROSS COUNTRY

10.2 LACK OF DATA ACCURACY

11 MARKET LANDSCAPE

11.1 MARKET OVERVIEW

11.2 MARKET SIZE & FORECAST

11.2.1 MARKET SHARE BY COMPONENT

11.2.2 MARKET SHARE BY DEVICES & SOFTWARE

11.2.3 MARKET SHARE BY APPLICATION

11.2.4 MARKET SHARE BY END-USER

11.3 FIVE FORCES ANALYSIS

11.3.1 THREAT OF NEW ENTRANTS

11.3.2 BARGAINING POWER OF SUPPLIERS

11.3.3 BARGAINING POWER OF BUYERS

11.3.4 THREAT OF SUBSTITUTES

11.3.5 COMPETITIVE RIVALRY

12 COMPONENT

12.1 MARKET SNAPSHOT & GROWTH ENGINE

13 DEVICES & SOFTWARE

13.1 MARKET SNAPSHOT & GROWTH ENGINE

13.2 MARKET OVERVIEW

13.2.1 MARKET SIZE & FORECAST

13.3 CARDIAC MONITORING DEVICES

13.3.1 MARKET OVERVIEW

13.3.2 MARKET SIZE & FORECAST

13.3.3 ELECTROCARDIOGRAPHS (ECGS): MARKET OVERVIEW

13.3.4 MARKET SIZE & FORECAST

13.3.5 CARDIAC MONITORS: MARKET OVERVIEW

13.3.6 MARKET SIZE & FORECAST

13.3.7 BLOOD PRESSURE MONITORS: MARKET OVERVIEW

13.3.8 MARKET SIZE & FORECAST

13.3.9 OTHERS: MARKET OVERVIEW

13.3.10 MARKET SIZE & FORECAST

13.4 RESPIRATORY MONITORING DEVICES

13.4.1 MARKET OVERVIEW

13.4.2 MARKET SIZE & FORECAST

13.4.3 APNEA MONITORS: MARKET OVERVIEW

13.4.4 MARKET SIZE & FORECAST

13.4.5 PULSE OXIMETERS: MARKET OVERVIEW

13.4.6 MARKET SIZE & FORECAST

13.4.7 OTHER RESPIRATORY MONITORING DEVICES: MARKET OVERVIEW

13.4.8 MARKET SIZE & FORECAST

13.5 BLOOD GLUCOSE MONITORS

13.5.1 MARKET OVERVIEW

13.5.2 MARKET SIZE & FORECAST

13.6 FETAL & NEONATAL MONITORING DEVICES

13.6.1 MARKET OVERVIEW

13.6.2 MARKET SIZE & FORECAST

13.7 OTHER RPM DEVICES

13.7.1 MARKET OVERVIEW

13.7.2 MARKET SIZE & FORECAST

14 SERVICES

14.1 MARKET OVERVIEW

14.2 MARKET SIZE & FORECAST

15 APPLICATION

15.1 MARKET SNAPSHOT & GROWTH ENGINE

15.2 MARKET OVERVIEW

15.3 CARDIOLOGY

15.3.1 MARKET OVERVIEW

15.3.2 MARKET SIZE & FORECAST

15.4 PULMONOLOGY

15.4.1 MARKET OVERVIEW

15.4.2 MARKET SIZE & FORECAST

15.5 ENDOCRINOLOGY

15.5.1 MARKET OVERVIEW

15.5.2 MARKET SIZE & FORECAST

15.6 OTHERS

15.6.1 MARKET OVERVIEW

15.6.2 MARKET SIZE & FORECAST

16 END-USER

16.1 MARKET SNAPSHOT & GROWTH ENGINE

16.2 MARKET OVERVIEW

16.3 HOSPITALS & SPECIALTY CLINICS

16.3.1 MARKET OVERVIEW

16.3.2 MARKET SIZE & FORECAST

16.4 HOMECARE SETTINGS

16.4.1 MARKET OVERVIEW

16.4.2 MARKET SIZE & FORECAST

16.5 AMBULATORY SURGICAL CENTERS

16.5.1 MARKET OVERVIEW

16.5.2 MARKET SIZE & FORECAST

16.6 LONG-TERM & ACUTE CARE CENTERS

16.6.1 MARKET OVERVIEW

16.6.2 MARKET SIZE & FORECAST

16.7 OTHERS

16.7.1 MARKET OVERVIEW

16.7.2 MARKET SIZE & FORECAST

17 COMPETITIVE LANDSCAPE

17.1 COMPETITION OVERVIEW BY DEVICES & SOFTWARE

17.1.1 MEDTRONIC

17.1.2 PHILIPS HEALTHCARE

17.1.3 RESMED

17.2 COMPETITION OVERVIEW BY SERVICES

17.2.1 MEDM

17.2.2 IHEALTHUNIFIEDCARE

17.2.3 QARDIO

18 KEY VENDORS

18.1 MEDTRONIC

18.1.1 BUSINESS OVERVIEW

18.1.2 PRODUCT OFFERING

18.2 PHILIPS HEALTHCARE

18.2.1 BUSINESS OVERVIEW

18.2.2 PRODUCT OFFERING

18.3 RESMED

18.3.1 BUSINESS OVERVIEW

18.3.2 PRODUCT OFFERING

19 OTHER PROMINENT VENDORS

19.1 100-PLUS

19.1.1 BUSINESS OVERVIEW

19.1.2 PRODUCT OFFERINGS

19.2 A&D COMPANY

19.2.1 BUSINESS OVERVIEW

19.2.2 PRODUCT OFFERINGS

19.3 ABBOTT

19.3.1 BUSINESS OVERVIEW

19.3.2 PRODUCT OFFERINGS

19.4 ALTUMVIEW SYSTEMS

19.4.1 BUSINESS OVERVIEW

19.4.2 PRODUCT OFFERINGS

19.5 BIOTRONIK

19.5.1 BUSINESS OVERVIEW

19.5.2 PRODUCT OFFERING

19.6 BOSTON SCIENTIFIC

19.6.1 BUSINESS OVERVIEW

19.6.2 PRODUCT OFFERINGS

19.7 BARDY DIAGNOSTICS

19.7.1 BUSINESS OVERVIEW

19.7.2 PRODUCT OFFERINGS

19.8 CARDIOMO CARE

19.8.1 BUSINESS OVERVIEW

19.8.2 PRODUCT OFFERINGS

19.9 CARDIOLOGS

19.9.1 BUSINESS OVERVIEW

19.9.2 PRODUCT OFFERINGS

19.10 DRAGERWERK AG

19.10.1 BUSINESS OVERVIEW

19.10.2 PRODUCT OFFERINGS

19.11 F. HOFFMANN-LA ROCHE

19.11.1 BUSINESS OVERVIEW

19.11.2 PRODUCT OFFERINGS

19.12 GE HEALTHCARE

19.12.1 BUSINESS OVERVIEW

19.12.2 PRODUCT OFFERINGS

19.13 GRANDCARE SYSTEMS

19.13.1 BUSINESS OVERVIEW

19.13.2 PRODUCT OFFERINGS

19.14 HONEYWELL INTERNATIONAL

19.14.1 BUSINESS OVERVIEW

19.14.2 PRODUCT OFFERINGS

19.15 IHEALTHUNIFIEDCARE

19.15.1 BUSINESS OVERVIEW

19.15.2 PRODUCT OFFERINGS

19.16 QARDIO

19.16.1 BUSINESS OVERVIEW

19.16.2 PRODUCT OFFERING

19.17 MEDM

19.17.1 BUSINESS OVERVIEW

19.17.2 PRODUCT OFFERING

19.18 MASIMO CORPORATION

19.18.1 BUSINESS OVERVIEW

19.18.2 PRODUCT OFFERINGS

19.19 MEDOPAD

19.19.1 BUSINESS OVERVIEW

19.19.2 PRODUCT OFFERINGS

19.20 NIHON KOHDEN

19.20.1 BUSINESS OVERVIEW

19.20.2 PRODUCT OFFERINGS

19.21 OMRON HEALTHCARE

19.21.1 BUSINESS OVERVIEW

19.21.2 PRODUCT OFFERINGS

19.22 OSPLABS

19.22.1 BUSINESS OVERVIEW

19.22.2 PRODUCT OFFERINGS

19.23 RESIDEO TECHNOLOGIES

19.23.1 BUSINESS OVERVIEW

19.23.2 .PRODUCT OFFERING

19.24 SMITHS MEDICAL

19.24.1 BUSINESS OVERVIEW

19.24.2 .PRODUCT OFFERINGS

19.25 SPACELABS HEALTHCARE

19.25.1 BUSINESS OVERVIEW

19.25.2 PRODUCT OFFERINGS

19.26 SENSEONICS

19.26.1 BUSINESS OVERVIEW

19.26.2 PRODUCT OFFERINGS

19.27 TELEMEDCARE

19.27.1 BUSINESS OVERVIEW

19.27.2 PRODUCT OFFERINGS

19.28 VITALCONNECT

19.28.1 PRODUCT OFFERINGS

19.29 VITLS

19.29.1 BUSINESS OVERVIEW

19.29.2 PRODUCT OFFERINGS

19.30 MODICARE

19.30.1 BUSINESS OVERVIEW

19.30.2 PRODUCT OFFERINGS

19.31 HILLROM

19.31.1 BUSINESS OVERVIEW

19.31.2 PRODUCT OFFERINGS

19.32 VIVIFY HEALTH

19.32.1 BUSINESS OVERVIEW

19.32.2 PRODUCT OFFERING

19.33 ACL DIGITAL

19.33.1 BUSINESS OVERVIEW

19.33.2 PRODUCT OFFERINGS

19.34 DEXCOM

19.34.1 BUSINESS OVERVIEW

19.34.2 PRODUCT OFFERING

19.35 IRHYTHM TECHNOLOGIES

19.35.1 BUSINESS OVERVIEW

19.35.2 PRODUCT OFFERING

19.36 VIVALINK

19.36.1 BUSINESS OVERVIEW

19.36.2 PRODUCT OFFERING

19.37 BIOBEAT

19.37.1 PRODUCT OFFERINGS

19.38 CAREVALIDATE

19.38.1 BUSINESS OVERVIEW

19.38.2 PRODUCT OFFERINGS

19.39 BIOFOURMIS

19.39.1 BUSINESS OVERVIEW

19.39.2 PRODUCT OFFERING

19.40 CAREMINDR

19.40.1 BUSINESS OVERVIEW

19.40.2 PRODUCT OFFERING

19.41 DATOS HEALTH

19.41.1 BUSINESS OVERVIEW

19.41.2 PRODUCT OFFERINGS

20 REPORT SUMMARY

20.1 KEY TAKEAWAYS

20.2 STRATEGIC RECOMMENDATIONS

21 QUANTITATIVE SUMMARY

21.1 MARKET BY COMPONENTS

21.1.1 MARKET BY DEVICES & SOFTWARE

21.1.2 MARKET BY CARDIAC MONITORING DEVICES

21.1.3 MARKET BY RESPIRATORY MONITORING DEVICES

21.2 MARKET BY APPLICATION

21.3 MARKET BY END USER

22 APPENDIX

22.1 ABBREVIATIONS

LIST OF EXHIBITS

EXHIBIT 1 SEGMENTATION OF US REMOTE PATIENT MONITORING MARKET

EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021

EXHIBIT 3 IMPACT OF TECHNOLOGICAL ADVANCEMENTS, IMPROVED CONNECTIVITY & REMOTE MONITORING

EXHIBIT 4 IMPACT OF TELEMEDICINE USHERING NEW OPPORTUNITIES FOR THE REMOTE MONITORING

EXHIBIT 5 IMPACT OF INCREASING ROLE OF INTERNET OF THINGS (IOT) FOR REMOTE MONITORING & HEALTHCARE

EXHIBIT 6 WAYS HEALTHCARE IOT & REMOTE PATIENT MONITORING ARE TRANSFORMING CARE DELIVERY

EXHIBIT 7 IMPACT OF INCREASING INNOVATIONS IN WEARABLE MEDICAL DEVICES

EXHIBIT 8 IMPACT OF GROWING USE OF MOBILE TECHNOLOGIES & SMART DEVICES FOR REMOTE PATIENT MONITORING

EXHIBIT 9 IMPACT OF AGING POPULATION VULNERABLE TO CHRONIC DISEASES

EXHIBIT 10 IMPACT OF GROWING USE OF RPM TO MONITOR & IMPROVE PATIENT ENGAGEMENT

EXHIBIT 11 IMPACT OF REGULATORY VARIATIONS ACROSS COUNTRY

EXHIBIT 12 IMPACT OF LACK OF DATA ACCURACY

EXHIBIT 13 US REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 14 US REMOTE PATIENT MONITORING MARKET BY COMPONENT

EXHIBIT 15 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE

EXHIBIT 16 US REMOTE PATIENT MONITORING MARKET BY APPLICATION

EXHIBIT 17 US REMOTE PATIENT MONITORING MARKET BY END-USER

EXHIBIT 18 FIVE FORCES ANALYSIS 2021

EXHIBIT 19 INCREMENTAL GROWTH BY COMPONENT 2021 & 2027

EXHIBIT 20 INCREMENTAL GROWTH BY DEVICES & SOFTWARE 2021 & 2027

EXHIBIT 21 US REMOTE PATIENT MONITORING MARKET BY PRODUCT

EXHIBIT 22 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: INCREMENTAL GROWTH

EXHIBIT 23 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE: ABSOLUTE GROWTH

EXHIBIT 24 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021–2027 ($ BILLION)

EXHIBIT 25 US REMOTE CARDIAC MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 26 US REMOTE CARDIAC MONITORING DEVICES MARKET 2021–2027 ($ BILLION)

EXHIBIT 27 US ECG REMOTE PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 28 US ECG REMOTE PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 29 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 30 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORS 2021–2027 ($ BILLION)

EXHIBIT 31 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 32 US REMOTE PATIENT MONITORING MARKET BY BLOOD PRESSURE MONITORS 2021–2027 ($ BILLION)

EXHIBIT 33 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 34 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)

EXHIBIT 35 US REMOTE RESPIRATORY MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 36 US REMOTE RESPIRATORY MONITORING DEVICES MARKET 2021–2027 ($ BILLION)

EXHIBIT 37 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 38 US REMOTE PATIENT MONITORING MARKET BY APNEA MONITORS 2021–2027 ($ BILLION)

EXHIBIT 39 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 40 US REMOTE PATIENT MONITORING MARKET BY PULSE OXIMETERS 2021–2027 ($ BILLION)

EXHIBIT 41 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 42 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)

EXHIBIT 43 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 44 US REMOTE PATIENT MONITORING MARKET BY BLOOD GLUCOSE MONITORS 2021–2027 ($ BILLION)

EXHIBIT 45 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 46 US REMOTE FETAL & NEONATAL MONITORING DEVICES MARKET 2021–2027 ($ BILLION)

EXHIBIT 47 US OTHER RPM DEVICES MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 48 US OTHER RPM DEVICES MARKET 2021–2027 ($ BILLION)

EXHIBIT 49 US REMOTE PATIENT MONITORING MARKET BY SERVICES: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 50 US REMOTE PATIENT MONITORING MARKET BY SERVICES 2021–2027 ($ BILLION)

EXHIBIT 51 INCREMENTAL GROWTH BY APPLICATION 2021 & 2027

EXHIBIT 52 US REMOTE PATIENT MONITORING MARKET BY APPLICATION

EXHIBIT 53 US REMOTE PATIENT MONITORING MARKET BY APPLICATION: INCREMENTAL GROWTH

EXHIBIT 54 US REMOTE CARDIOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 55 US REMOTE CARDIOLOGY PATIENT MONITORING 2021–2027 ($ BILLION)

EXHIBIT 56 US REMOTE PULMONOLOGY PATIENT MONITORING: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 57 US REMOTE PULMONOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 58 US REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 59 US REMOTE ENDOCRINOLOGY PATIENT MONITORING MARKET 2021–2027 ($ BILLION)

EXHIBIT 60 US REMOTE PATIENT MONITORING MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 61 US REMOTE PATIENT MONITORING MARKET BY OTHERS 2021–2027 ($ BILLION)

EXHIBIT 62 INCREMENTAL GROWTH BY END-USER 2021 & 2027

EXHIBIT 63 US REMOTE PATIENT MONITORING MARKET BY END-USER

EXHIBIT 64 US REMOTE PATIENT MONITORING MARKET BY END-USER: INCREMENTAL GROWTH

EXHIBIT 65 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 66 US REMOTE PATIENT MONITORING MARKET BY HOSPITALS & SPECIALTY CLINICS 2021–2027 ($ BILLION)

EXHIBIT 67 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 68 US REMOTE PATIENT MONITORING MARKET BY HOMECARE SETTINGS 2021–2027 ($ BILLION)

EXHIBIT 69 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 70 US REMOTE PATIENT MONITORING MARKET BY AMBULATORY SURGICAL CENTERS 2021–2027 ($ BILLION)

EXHIBIT 71 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 72 US REMOTE PATIENT MONITORING MARKET BY LONG-TERM & ACUTE CARE CENTERS 2021–2027 ($ BILLION)

EXHIBIT 73 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS: INCREMENTAL & ABSOLUTE GROWTH

EXHIBIT 74 US REMOTE PATIENT MONITORING MARKET BY OTHER END-USERS 2021–2027 ($ BILLION)

EXHIBIT 75 MEDTRONIC REVENUE 2018-2021 ($ BILLION)

EXHIBIT 76 MEDTRONIC SEGMENT 2021 (%)

EXHIBIT 77 PHILIPS HEALTHCARE SEGMENT 2021 (%)

EXHIBIT 78 PHILIPS HEALTHCARE REVENUE 2018-2021 ($ BILLION)

EXHIBIT 79 PHILIPS HEALTHCARE REGIONAL REVENUE 2021 (%)

EXHIBIT 80 RESMED REVENUE BY SEGMENT 2021 (%)

EXHIBIT 81 RESMED REVENUE 2018-2021 ($ BILLION)

LIST OF TABLES

TABLE 1 KEY CAVEATS

TABLE 2 CURRENCY CONVERSION 2015−2021

TABLE 3 MEDTRONIC: MAJOR PRODUCT OFFERINGS

TABLE 4 COVIDIEN PLC.: MAJOR PRODUCT OFFERINGS

TABLE 5 PHILIPS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 6 RESMED: MAJOR PRODUCT OFFERINGS

TABLE 7 100-PLUS: MAJOR PRODUCT OFFERINGS

TABLE 8 A&D COMPANY: MAJOR PRODUCT OFFERINGS

TABLE 9 ABBOTT: MAJOR PRODUCT OFFERINGS

TABLE 10 ALTUMVIEW SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 11 BIOTRONIK: MAJOR PRODUCT OFFERINGS

TABLE 12 BOSTON SCIENTIFIC: MAJOR PRODUCT OFFERINGS

TABLE 13 BARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS

TABLE 14 CARDIOMO CARE: MAJOR PRODUCT OFFERINGS

TABLE 15 CARDIOLOGS: MAJOR PRODUCT OFFERINGS

TABLE 16 DRAGERWERK AG: MAJOR PRODUCT OFFERINGS

TABLE 17 F. HOFFMANN-LA ROCHE.: MAJOR PRODUCT OFFERINGS

TABLE 18 ROCHE DIABETES CARE. MAJOR PRODUCT OFFERINGS

TABLE 19 GE HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 20 GRANDCARE SYSTEMS: MAJOR PRODUCT OFFERINGS

TABLE 21 HONEYWELL INTERNATIONAL: MAJOR PRODUCT OFFERINGS

TABLE 22 IHEALTHUNIFIEDCARE: MAJOR PRODUCT OFFERINGS

TABLE 23 QARDIO: MAJOR PRODUCT OFFERINGS

TABLE 24 MEDM: MAJOR PRODUCT OFFERINGS

TABLE 25 MASIMO CORPORATION: MAJOR PRODUCT OFFERINGS

TABLE 26 MEDOPAD.: MAJOR PRODUCT OFFERINGS

TABLE 27 NIHON KOHDEN: MAJOR PRODUCT OFFERINGS

TABLE 28 OMRON HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 29 OSPLABS: MAJOR PRODUCT OFFERINGS

TABLE 30 RESIDEO TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 31 SMITHS MEDICAL: MAJOR PRODUCT OFFERINGS

TABLE 32 SPACELABS HEALTHCARE: MAJOR PRODUCT OFFERINGS

TABLE 33 SENSEONICS: MAJOR PRODUCT OFFERINGS

TABLE 34 TELEMEDCARE: MAJOR PRODUCT OFFERINGS

TABLE 35 VITALCONNECT: MAJOR PRODUCT OFFERINGS

TABLE 36 VITLS: MAJOR PRODUCT OFFERINGS

TABLE 37 MODICARE: MAJOR PRODUCT OFFERINGS

TABLE 38 WELCH ALLYN: MAJOR PRODUCT OFFERINGS

TABLE 39 VIVIFY HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 40 ACL DIGITAL: MAJOR PRODUCT OFFERINGS

TABLE 41 DEXCOM: MAJOR PRODUCT OFFERINGS

TABLE 42 IRHYTHM TECHNOLOGIES: MAJOR PRODUCT OFFERINGS

TABLE 43 VIVALINK: MAJOR PRODUCT OFFERINGS

TABLE 44 BIOBEAT: MAJOR PRODUCT OFFERINGS

TABLE 45 CAREVALIDATE: MAJOR PRODUCT OFFERINGS

TABLE 46 BIOFOURMIS: MAJOR PRODUCT OFFERINGS

TABLE 47 CAREMINDR: MAJOR PRODUCT OFFERINGS

TABLE 48 DATOS HEALTH: MAJOR PRODUCT OFFERINGS

TABLE 49 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 ($ BILLION)

TABLE 50 US REMOTE PATIENT MONITORING MARKET BY COMPONENT 2021−2027 (%)

TABLE 51 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 ($ BILLION)

TABLE 52 US REMOTE PATIENT MONITORING MARKET BY DEVICES & SOFTWARE 2021−2027 (%)

TABLE 53 US REMOTE PATIENT MONITORING MARKET BY  CARDIAC MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 54 US REMOTE PATIENT MONITORING MARKET BY CARDIAC MONITORING DEVICES 2021−2027 (%)

TABLE 55 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 ($ BILLION)

TABLE 56 US REMOTE PATIENT MONITORING MARKET BY RESPIRATORY MONITORING DEVICES 2021−2027 (%)

TABLE 57 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 ($ BILLION)

TABLE 58 US REMOTE PATIENT MONITORING MARKET BY APPLICATION 2021−2027 (%)

TABLE 59 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 ($ BILLION)

TABLE 60 US REMOTE PATIENT MONITORING MARKET BY END-USER 2021−2027 (%)

Select a license type that suits your business needs

single-user Single User Licence
$2995.00
  • Report accessible by one user only
  • Free 10% or 3 days of customization
  • Free post-sale service assistance
  • Continuous support through email
Best Value Tag
5-user 5 User Licence
$3495.00
  • Report accessible by 5 users within the organization
  • Free 15% or 4.5 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
corporate.png Corporate Licence
$4495.00
  • Free Datasheet worth $1500
  • Report accessible by the entire organization
  • Free 20% or 6 days of customization
  • Free post-sale service assistance
  • Continuous support through email and telephone
  • Direct access to lead analysts
  • Free analyst hour
  • Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
datasheet.png Datasheet Licence
$1000.00
  • Report accessible by 1 user only
  • Free 15% or 32 hours of customization
  • Free post-sale service assistance
  • Direct access to lead analysts

Our Clients

Licence Types What are these?

Our Clients Speak

erick

"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."

Erik Young
CEO, Co-founder
Audink Inc., DBA Audios
SPEAK WITH OUR ANALYST

Want to know more about the report or any specific requirement?

Click to Email +1-312-235-2040

Want to Customize the Report?

Click Here

Why Arizton?

  • 100% Customer Satisfaction
  • 24x7 availability – we are always there when you need us
  • 200+ Fortune 500 Companies trust Arizton's report
  • 80% of our reports are exclusive and first in the industry
  • 100% more data and analysis
  • 1000+ reports published till date